Raman spectroscopic study of radioresistant oral cancer sublines established by fractionated ionizing radiation

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Yasser, Mohd ^a   Shaikh, Rubina ^a   Chilakapati, Murali Krishna ^a   Teni, Tanuja ^a  

^a TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; PROTEIN BCL 2; PROTEIN MCL 1; SURVIVIN;

ARTICLE; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA CONTENT; FILOPODIUM; FRACTIONATED IONIZING RADIATION; HUMAN; HUMAN CELL; IONIZING RADIATION; ORAL CANCER CELL LINE; PRINCIPAL COMPONENT ANALYSIS; PROTEIN EXPRESSION; RADIOSENSITIVITY; RAMAN SPECTROMETRY; ANALYSIS OF VARIANCE; CELL SURVIVAL; MOUTH TUMOR; PROCEDURES; RADIATION DOSE; RADIATION RESPONSE; RADIOGRAPHY; TUMOR CELL LINE; WESTERN BLOTTING;

ANALYSIS OF VARIANCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; MOUTH NEOPLASMS; PRINCIPAL COMPONENT ANALYSIS; RADIATION TOLERANCE; RADIATION, IONIZING; SPECTRUM ANALYSIS, RAMAN;

EID: 84901296950     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097777     Document Type: Article

References (55)

1. Ferlay J, Shin HR, Bray D, Forman D, Mathers C, et al. (2010) Estimates of worldwide burden of cancer in 2008. Int J Cancer 127: 2893-2917.
2. Dikshit R, Gupta PC, Ramasundarahettige C, Gajalakshmi V, Aleksandrowicz L, et al. (2012) Cancer mortality in India: a nationally representative survey. The Lancet. doi: 10.1016/S0140-6736(12)60358-4.
3. th edition.
4. Singh AD, Von Essen CF (1966) Buccal mucosa cancer in south India; etiologic and clinical aspects. Am J Roentgenol 96: 1.
5. Bessell A, Glenny AM, Furness S, Clarkson JE, Oliver R, et al. (2011) Interventions for the treatment of oral and oropharyngeal cancers: surgical treatment. Cochrane Database System Rev 9:CD006205.
6. Huang SH, Sullivan BO (2013) Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal 18(2):e233-40.
7. John-Aryankalayil M, Palayoor ST, Cerna D, Simone CB 2nd, Falduto MT, et al. (2010) Fractionated radiation therapy can induce a molecular profile for therapeutic targeting. Radiat Res 174: 446-458.
8. Martínez Carrillo M, Tovar Martín I, Martínez Lara I, Ruiz de Almodóvar Rivera JM, Del Moral Ávila R (2013) Selective use of postoperative neck radiotherapy in oral cavity and oropharynx cancer: a prospective clinical study. Radiat Oncol 8: 103. doi: 10.1186/1748-717X-8-103.
9. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, et al. (2006) Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 9; 354(6): 567-78.
10. Bucci B, Misiti S, Cannizzaro A, Marchese R, Raza GH, et al. (2006) Fractionated ionizing radiation exposure induces apoptosis through caspase-3 activation and reactive oxygen species generation. Anticancer Res 26: 4549-4558.
11. Fenton RG, Longo DL (2011) Cancer cell biology and angiogenesis. Harrison's Principles of Internal Medicine, 18th Edition, p. 294-317.
12. Bates S, Vousden KH (1996) p53 in signalling checkpoint arrest or apoptosis. Curr Opin Genet Dev 6: 12-18. (Pubitemid 26059045)
13. Terakado N, Shintani S, Yano J, Chunnan L, Mihara M, et al. (2004) Overexpression of cyclooxygenase-2 is associated with radioresistance in oral squamous cell carcinoma. Oral Oncol 40: 383-9. (Pubitemid 38221385)
14. Sklar MD, Thompson E, Welsh MJ, Liebert M, Harney J, et al. (1991) Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells. Mol Cell Biol 11(7): 3699.
15. Osaki M, Oshimura M, Ito H (2004) PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis 9(6): 667-76. (Pubitemid 40941196)
16. Chen J, Lin J, Levine AJ (1995) Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene. Mol Med 1: 142-152.
17. Shannan B, Seifert M, Boothman DA, Tilgen W, Reichrath J (2006) Clusterin and DNA repair: a new function in cancer for a key player in apoptosis and cell cycle control. J Mol Histol 37(5-7): 183-188. (Pubitemid 44795623)
18. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3: 917-921. (Pubitemid 27353455)
19. Kitada S, Miynshita T, Tanaka S, Reed JC (1993) Investigations of antisense oligonnuleotides targeted against bcl-2 RNAs. Antisense Res & Develop 3: 157-169. (Pubitemid 23243676)
20. Skvara H, Thallinger C, Wacheck V, Monia BP, Pehamberger H, et al. (2005) Mcl-1 Blocks Radiation-induced Apoptosis and Inhibits Clonogenic Cell Death. Anticancer Res 25: 2697-2704. (Pubitemid 41044649)
21. De Veld DC, Witjes MJ, Sterenborg HJ, Roodenburg JL (2005) The status of in vivo autofluorescence spectroscopy and imaging for oral oncology. Oral Oncol 41(2): 117-131. (Pubitemid 40202877)
22. Wu JG, Xu YZ, Sun CW, Soloway RD, Xu DF, et al. (2001) Distinguishing malignant from normal oral tissues using FTIR fiber-optic techniques. Biopolymers 62(4): 185-192. (Pubitemid 32552796)
23. Ferreira DS, Coutinho PG, Castanheira ES, Correia JH, Minas G (2010) Fluorescence and diffuse reflectance spectroscopy for early cancer detection using a new strategy towards the development of a miniaturized system. Conf Proc IEEE Eng Med Biol Soc 1210(3). doi: 10.1109/IEMBS.2010.5626448.
24. Venkatakrishna K, Kurien J, Pai KM, Murali Krishna C, Ullas G, et al. (2001) Optical pathology of oral tissue: A Raman spectroscopy diagnostic method. Curr Sci 80(1): 665-669. (Pubitemid 33616282)
25. Krishna CM, Sockalingum GD, Kurien J, Rao L, Venteo L, et al. (2004) Micro-Raman spectroscopy for optical pathology of oral squamous cell carcinoma. Appl Spectrosc 58(9): 1128-1135.
26. Malini R, Venkatakrishna K, Kurien J, Pai KM, Rao L, et al. (2006) Discrimination of normal, inflammatory premalignant, and malignant oral tissue: a Raman spectroscopy study. Biopolymers 81(3): 179-193.
27. Nijssen A, Koljenovic S, Schut TCB, Caspers PJ, Pupples GJ (2009) Towards oncological application of Raman spectroscopy. J Biophoton 2(1-2): 29-36.
28. Singh SP, Deshmukh A, Chaturvedi P, Krishna CM (2012) Raman spectroscopy in head and neck cancers: Toward oncological applications. J Cancer Res Ther 8(6): 126-132.
29. Singh SP, Deshmukh A, Chaturvedi P, Krishna CM (2012) In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa. J Biomed Opt 17(10): 105002. doi:10.1117/1.jbo.17.10.105002.
30. Rubina S, Maheswari A, Deodhar KK, Bharat R, Krishna CM (2013) Raman spectroscopic study on classification of cervical cell specimens. Vib Spectrosc 68: 115-121.
31. Rubina S, Vidyasagar MS, Krishna CM (2013) Raman spectroscopic study on prediction of treatment response in cervical cancers. J Innov Opt Health Sci 6(2): 1350014.
32. Singh SP, Sahu A, Deshmukh A, Chaturvedi P, Krishna CM (2013) In vivo Raman spectroscopy of oral buccal mucosa:a study on malignancy associated changes (MAC)/cancer field effects (CFE). Analyst 138: 4175-4182.doi: 10.1039/c3an36761d.
33. Sahu A, Dalal K, Naglot S, Aggarwal P, Krishna CM (2013) Serum Based Diagnosis of Asthma Using Raman Spectroscopy: An Early Phase Pilot Study. Plos one 8(11): e78921. doi:10.1371/journal.pone.0078921.
34. Sahu A, Sawant S, Mamgain H, Krishna CM (2013) Raman spectroscopy of serum: an exploratory study for detection of oral cancers. Analyst. doi: 10.1039/c3an00308f.
35. Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, et al. (2006) Combined Fourier transform infrared and Raman spectroscopic approach for identification of multidrug resistance phenotype in cancer cell lines. Biopolymers 82(5): 462-70. (Pubitemid 44126358)
36. Krishna CM, Kegelaer G, Adt I, Rubin S, Kartha VB, et al. (2005) Characterisation of uterine sarcoma cell lines exhibiting MDR phenotype by vibrational spectroscopy. Biochim Biophys Acta 1726(2): 160-7. (Pubitemid 41572255)
37. Matthews Q, Brolo A, Lum J, Duan X, Jirasek A (2011) Raman spectroscopy of single human tumour cells exposed to ionizing radiation in vitro. Phys Med Biol 56(1): 19-38.
38. Matthews Q, Jirasek A, Lum JJ, Brolo AG (2011) Biochemical signatures of in vitro radiation response in human lung, breast and prostate tumour cells observed with Raman spectroscopy. Phys Med Biol 56(21): 6839-55.
39. Martin CL, Reshmi SC, Ried T, Gottberg W, Wilson JW, et al. (2008) Chromosomal imbalances in oral squamous cell carcinoma. Examination of 31 cell lines and review of the literature. Oral Oncol 44(4): 369-382. (Pubitemid 351380982)
40. Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protocol 1(5): 2315-9.
41. Lowry OH, Rosenborough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193: 65-75.
42. Nijssen A, Maquelin K, Caspers PJ, Schut TCB, Neumann MHA, et al. (2007) Discriminating basal cell carcinoma from perilesional skin using high wave-number Raman spectroscopy. J Biomed Opt 12(3): 034004-1.
43. Koljenovic S, Choo-Smith LP, Schut TCB, Kros JM, Berge HJ, et al. (2002) Discriminating vital tumor from necrotic tissue in human glioblastoma tissue samples by Raman spectroscopy. Lab Invest 82(10): 1265-1277. (Pubitemid 35191530)
44. Ghanate AD, Kothiwale S, Singh SP, Bertrand D, Krishna CM (2011) Comparative evaluation of spectroscopic models using different multivariate statistical tools in a multicancer scenario. J Biomed Opt 16: 025003.
45. Wang B, Xie M, Li R, Owonikoko TK, Ramalingam SS, et al. (2014) Role of Ku70 in deubiquitination of Mcl-1 and suppression of apoptosis. Cell Death Differ. doi: 10.1038/cdd.2014.42.
46. Mallick S, Patil R, Gyanchandani R, Pawar S, Palve V, et al. (2009) Human oral cancers have altered expression of Bcl-2 family members and increased expression of the anti-apoptotic splice variant of Mcl-1. J Patho 217: 398-407.
47. Palve V, Teni TR (2012) Association of anti-apoptotic Mcl-1L isoform expression with radioresistance of oral squamous carcinoma cells. Radiation Oncology 7: 135-146.
48. Ishigami T, Uzawa K, Higo M, Nomura H, Saito K, et al. (2007) Genes and molecular pathways related to radioresistance of oral squamous cell carcinoma cells. Int J Cancer 120: 2262-2270. (Pubitemid 46555867)
49. Moosmann B, Behl C (2000) Cytoprotective antioxidant function of tyrosine and tryptophan residues in transmembrane proteins. Eur J Biochem 267(18): 5687-5692.
50. Yamamori T, Yasui H, Yamazumi M, Wada Y, Nakamura Y (2012) Ionizing radiation induces mitochondrial reactive oxygen species production accompanied by upregulation of mitochondrial electron transport chain function and mitochondrial content under control of the cell cycle checkpoint. Free Radic Biol Med 53(2): 260-70.
51. Valko M, Izakovic M, Mazur M, Rhodes CJ, Telser J (2004) Role of oxygen radicals in DNA damage and cancer incidence. Molecular and Cellular Biochemistry 266 (1-2): 37-56. (Pubitemid 39562306)
52. Sun J, Chen Y, Li M, Ge Z (1998) Role of antioxidant enzymes on ionizing radiation resistance. Free Radic Biol Med 24(4): 586-593. (Pubitemid 28150477)
53. Yasuda H (2008) Solid tumor physiology and hypoxia-induced chemo/radio-resistance: Novel strategy for cancer therapy: Nitric oxide donor as a therapeutic enhancer. Nitric Oxide 19(2): 205-216.
54. Chapman JD, Engelhardt EL, Stobbe CC, Schneider RF, Hanks GE (1998) Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. Radiother Oncol 46: 229-237. (Pubitemid 28157272)
55. Lee HC, Kim DW, Jung KY, Park IC, Park MJ, et al. (2004) Increased expression of antioxidant enzymes in radioresistant variant from U251 human glioblastoma cell line. Int J Mol Med 13(6): 883-887.